What should Australian Shepherd owners know about genetics and genetic health?

A practical guide to Australian Shepherd genetic health: MDR1 drug-sensitivity, hip dysplasia, epilepsy, eye disease (cataracts/coloboma), double-merle dangers, and breeder/testing advice.

Overview

Australian Shepherds are intelligent, energetic herding dogs with several well‑characterized genetic health risks. Knowing which conditions are inherited, how they present, and which genetic and clinical tests to request will help you make informed choices when buying, breeding, or managing an Aussie.

This guide covers the high-priority issues: the MDR1 (ABCB1) drug-sensitivity mutation, hip dysplasia, epilepsy, inherited eye problems (cataracts and coloboma), the severe sensory risks from double‑merle matings, and autoimmune disorders. For each condition you'll find what it is, how common or important it is, recommended tests and screening, and practical steps for prevention and management.

Primary references for this article include the American Kennel Club (AKC), Merck Veterinary Manual, the UC Davis Veterinary Genetics Laboratory (VGL), the Orthopedic Foundation for Animals (OFA), and peer‑reviewed veterinary pharmacogenetics research (Mealey et al.).

MDR1 (ABCB1) — why this matters to every Aussie owner

What it is

• MDR1 (multi‑drug resistance 1, gene symbol ABCB1) encodes P‑glycoprotein (P‑gp), a drug‑export pump that helps keep certain drugs out of the brain.
• A specific 4‑base pair deletion (often called MDR1‑1Δ) reduces or eliminates P‑gp function and causes increased sensitivity to several commonly used drugs.

• The MDR1 mutation is common in collie‑line herding breeds, including Australian Shepherds. Dogs with two copies (homozygous mutant) are at highest risk; heterozygotes (one copy) may have intermediate sensitivity.
• When affected dogs are exposed to P‑gp substrate drugs, they can develop severe neurologic signs (tremors, ataxia, coma) and even death at doses that are safe in normal dogs.

• Ivermectin at high doses (and sometimes even at routine doses used for certain parasites), loperamide (Imodium), some macrocyclic lactones, certain anticancer drugs (vincristine, vinblastine), and some sedatives/antipsychotics.
• The UC Davis VGL and numerous veterinary reviews list drug classes and examples — always check a current reference before treating an MDR1 mutant dog ([UC Davis VGL MDR1 info](https://vgl.ucdavis.edu)).

• A simple DNA test (cheek swab or blood) detects the MDR1 deletion. Many labs (UC Davis VGL, commercial veterinary genetics labs) offer it.
• Results: clear (no mutation), carrier (one copy), or affected/at‑risk (two copies). Record results in your dog’s medical file and on any breeder paperwork.

• Test all Australian Shepherds. The American Veterinary Medical Association (AVMA) and veterinary geneticists recommend routine MDR1 testing in herding breeds.
• If your dog is carrier/affected, provide a wallet card or note to your vet with the result. Avoid listed drugs or use extreme caution and alternative drugs when possible.
• If you breed, never mate two merle carriers without knowing MDR1 status of the parents and offspring; MDR1 and merle are different genes but both important to screen.

Hip dysplasia — musculoskeletal screening and management

What it is

• Canine hip dysplasia (CHD) is a developmental disorder of the hip joint leading to looseness, arthritis, and pain.
• Multifactorial inheritance: polygenic genetic risk plus environmental contributors (nutrition, growth rate, body weight, exercise as a puppy).

• Australian Shepherds are a medium‑to‑large active breed; CHD can limit lifetime function if severe. Breeder screening reduces disease incidence over generations.

• OFA (Orthopedic Foundation for Animals) radiographic hip scoring (typically submitted at or after 24 months for definitive evaluation).
• PennHIP (distraction index) can be performed earlier (as young as 16 weeks) and gives an objective measure of laxity; DI >0.60 is associated with increased risk of developing osteoarthritis.

• Puppies: avoid inappropriate rapid growth (balanced diet, avoid excess calories), heavy repetitive high‑impact exercise while growth plates are open.
• Breeding: require parents to have acceptable hip evaluations (OFA/PennHIP) and use those metrics when selecting against CHD.
• If your dog develops stiffness or lameness, seek veterinary assessment early — weight management, NSAIDs, joint supplements (omega‑3s, chondroitin/glucosamine), physical therapy, and in some cases surgery (juvenile pubic symphysiodesis, triple pelvic osteotomy) can help.

Epilepsy — inherited seizure risk and management

What it is

• Idiopathic epilepsy is recurrent seizures without an identifiable metabolic or structural cause. In many breeds, a heritable form exists.

• Australian Shepherds are among breeds reported with inherited epilepsy in veterinary literature; age of onset is usually 6 months to 5 years.

• A thorough workup includes history, neurologic exam, baseline bloodwork (CBC/Chemistry, thyroid), and sometimes MRI/CSF to rule out structural causes. Referral to a veterinary neurologist is appropriate for difficult cases.

• First‑line antiepileptic drugs commonly include phenobarbital, potassium bromide, levetiracetam, and zonisamide. Dosing and drug choice must consider MDR1 status (some drugs and drug interactions are P‑gp substrates).
• Treatment focuses on reducing seizure frequency and severity while monitoring for adverse effects with periodic blood testing.

• If your Aussie has a first seizure, seek veterinary assessment promptly. Collect a detailed timeline and video of events if possible.
• Discuss long‑term management options and the potential for genetic counseling before breeding an affected dog.

Eye disease: cataracts, coloboma, and merle‑related ocular defects

Common inherited ocular issues

• Cataracts: focal or progressive lens opacities that can impair vision; some cataracts in Aussies have hereditary forms.
• Coloboma: a congenital defect (hole or notch) in ocular structures; part of the collie/merle ocular spectrum and can be associated with visual deficits.
• Merle‑associated microphthalmia and other structural ocular abnormalities can occur in double‑merle dogs (see next section).

• Annual eye exams by a boarded veterinary ophthalmologist (ACVO diplomate) are recommended, starting in puppyhood and continuing annually in breeding animals.
• The Canine Eye Registration Foundation (CERF) and OFA/ACVO eye certificate provide documentation of normal ocular status — required by many responsible breeders.

• Ask breeders for recent ophthalmologist exam reports on both parents and request the puppy’s initial eye exam before purchase.
• If your dog develops cloudiness, abnormal pupil shape, visual behavior changes, or ocular discharge, seek prompt ophthalmic evaluation.

Double merle — the avoidable catastrophe

What is a double merle?

• Merle is a coat‑pattern allele that is dominant. When two merle dogs are bred, approximately 25% of puppies (the double‑merles) can inherit two merle alleles.

• Double‑merle dogs commonly have severe congenital auditory and visual deficits including deafness, microphthalmia, colobomas, and total blindness. The condition is preventable with responsible breeding.

• Never breed two merle carriers together. Reputable breeders avoid merle × merle matings and genotype for merle when appropriate.
• If you buy a merle puppy, confirm the pup and both parents have ophthalmologist exams and full health clearances; ask for a hearing test (BAER) if indicated.

Autoimmune conditions — what to watch for

What they are

• Autoimmune disorders occur when the immune system attacks the dog’s own tissues. In dogs the most common autoimmune conditions include hypothyroidism (immune‑mediated lymphocytic thyroiditis), immune‑mediated hemolytic anemia (IMHA), and certain dermatologic syndromes.

• While not the highest‑risk breed for every autoimmune disease, Australian Shepherds are reported to have cases of autoimmune thyroiditis, IMHA and immune‑mediated skin disease in the literature and breed health reports.

• Baseline annual wellness bloodwork that includes thyroid testing (if clinically indicated) helps early detection. Be alert for signs: unexplained lethargy/weight changes (thyroid), sudden jaundice or weakness (IMHA), and unexplained skin lesions or chronic ear disease.
• Autoimmune disease often requires specialist care (internal medicine) and long‑term immunosuppressive medication.

Practical checklist for owners and prospective buyers

• Test for MDR1: perform DNA testing on puppies and adults; record results with your veterinarian.
• Eye exams: ACVO ophthalmologist exam on both parents and puppies; annual eye checks for breeding animals.
• Hip screening: OFA or PennHIP evaluations for breeding animals; manage puppy nutrition and weight to reduce hip risk.
• Seizures: investigate any seizure with your vet/neurologist and avoid breeding affected animals without genetic counseling.
• Avoid merle × merle breedings to prevent double‑merle outcomes.
• Keep a health record: DNA test results, hip and eye certificates, and any reproductive or illness history make better breeding decisions and improve puppy placement.

When to involve specialists

• Board‑certified veterinary ophthalmologist (ACVO) for congenital or progressive eye issues.
• Veterinary neurologist for recurrent seizures or complex seizure workups.
• Veterinary internal medicine specialist for autoimmune diseases or complicated cases.

Resources and where to test

• UC Davis Veterinary Genetics Laboratory (VGL) — MDR1 and many other canine genetic tests: https://vgl.ucdavis.edu
• Orthopedic Foundation for Animals (OFA) — hip and elbow evaluations, eye registry: https://www.ofa.org
• Merck Veterinary Manual — clinical overviews: https://www.merckvetmanual.com
• American Kennel Club (AKC) — breed health information: https://www.akc.org
• Consult your primary veterinarian for referrals to ACVO ophthalmologists, ACVIM neurologists, and genetic counselors.

Key Takeaways

• MDR1 testing is essential for Australian Shepherds: it prevents life‑threatening drug reactions and informs safe prescribing.
• Hip dysplasia, epilepsy, and hereditary eye disease (cataracts, coloboma) are important in Aussies; screening through OFA/PennHIP and ACVO exams reduces disease burden.
• Double‑merle matings can produce puppies with deafness and blindness — avoid merle × merle breeding.
• Autoimmune conditions occur and require prompt veterinary care and sometimes specialist management.
• Before buying or breeding: request MDR1 status, hip and eye clearances, and health histories from both parents; keep records and involve specialists when needed.

Selected citations and resources

• UC Davis Veterinary Genetics Laboratory — MDR1 and breed testing: https://vgl.ucdavis.edu
• Mealey K.L., et al. Ivermectin sensitivity in collie dogs is associated with a deletion mutation of the MDR1 gene. J Vet Pharmacol Ther. 2001;24 Suppl 1:79–81.
• Merck Veterinary Manual — Seizure disorders, Hip dysplasia, Autoimmune disease: https://www.merckvetmanual.com
• Orthopedic Foundation for Animals (OFA): https://www.ofa.org
• American Kennel Club — Australian Shepherd health and breed info: https://www.akc.org

Frequently Asked Questions